skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical and Evolus working together to launch Nabota
Date 2018-10-05 Hit 2298
News List
Prev FDA resumes review of Daewoong Pharmaceutical’s Nabota
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval